eSignal IPO Calendar

Week of Expected Pricing	10/14/2021
Company Name	BONE BIOLOGICS CORP
Proposed Ticker	BBLG
CUSIP	98070204
Business Description	A medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein, known as NELL-1/DBX®. The NELL-1/DBX® combination product is an osteostimulative recombinant protein that provides target specific control over bone regeneration.
Lead Underwriter	WallachBeth Capital, LLC
Co-Managers	N/A
Initial Shares	9,50,000
Revised Initial Shares	N/A
Initial Price	N/A
Revised Price	N/A
Final Price	$5.24
Final Ticker	BBLG